uniQure
uniqure.com
Actively hiring
Biotechnology
Genomics & Genetic Testing
Cell & Gene Therapy
As featured in
View 5 jobs
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Funding and backers
Hiring now
21
+13 posted in 30 days
Backers
1
Foresite Capital
Momentum
25/100
hiring for its size
Last sign of life
this month
a posting or a news item
Registers and programsofficial lists and records that name the company
| Legal entity | Qure N.V. | its site |
Backed byfrom the funds' portfolios and accelerator catalogs
Foresite Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Universal access to high quality delivery platforms for developers of genomics medicines. A new path for biotechnologists.
Revolutionizing genomic medicines. Inspired by patients, directed by nature’s intelligence.
High science that delivers.. Developing in vivo gene editing therapeutics to transform patient lives.
Discover WhiteLab Genomics, where AI meets biology to revolutionize genomic medicine. Our innovative platform optimizes drug design for…
Developing scalable in-vivo genomic medicine for blood disorders.
ChromaCode is a leading provider of HDPCR™ multiplexing technology for genomic solutions. Our breakthrough platform enables labs…
News
Why a Huntington's patient isn't fazed by the waning effect of UniQure's gene therapy
Questions about the durability of the therapy, AMT-130, may matter more to Wall Street than those directly affected by the disease.
Read more
Report
uniQure (QURE) Faces A Fresh AMT 130 Test After Mixed Data, Bargain Or Trap
uniQure (NasdaqGS:QURE) is back in focus after new 36- and 48-month data for its Huntington's gene therapy, AMT-130, sparked sharp swings in the share price and renewed debate about the program. uniQure's share price has been hit hard in the wake of the m
Read more
Report
AstraZeneca buys into Summit, UniQure drops on 4-year data, FDA on a roll
Summit Therapeutics scores a $2 billion equity investment from AstraZeneca to support ivonescimab's late-stage development; uniQure crashes after four-year data from its Huntington's disease gene therapy failed to impress; Kyverna Therapeutics brings new
Read more
Report
Report
uniQure BLA Filed as AMT-130 Shows 4-Year Huntington's Functional Benefit
uniQure (NASDAQ:QURE) reported updated Phase I/II data for its investigational Huntington's disease gene therapy, ifezuntirgene inilparvovec, or AMT-130, including 36-month results from all high-dose patients and 48-month results from the first 12 high-do
Read more
Report
uniQure Announces Additional Data from Ongoing Phase I/II Studies of ifezuntirgene inilparvovec (AMT-130) in Huntington's Disease Showing Continued Slowing of Disease Progression
In 12 high-dose patients at 48 months, both cUHDRS and TFC continued to demonstrate meaningful slowing of disease progression and clear dose-dep...
Read more
Report
UniQure's gene therapy continues to slow Huntington's progression after four years
The gene therapy continued to slow progression of the neurodegenerative disease four years after it was surgically implanted in patient's brains.
Read more
Report
UniQure tumbles with latest data for Huntington's gene therapy
Analysts guessed that investors wanted to see stronger durability results at a four-year check-in of the key trial supporting a potential approval of "AMT-130."
Read more
Report
Show more news
Tech stack
Technologies named in job postings at uniQure over the last 12 months, by layer, with the share of postings for each.
Technologies in use
22
Postings analysed
10
Stack modernity
77/100AI adopter
Languages
Python30%
SQL30%
JavaScript10%
SAS10%
Databases
Snowflake20%
Cloud & platforms
Microsoft Fabric30%
Power BI30%
Azure10%
Azure DevOps10%
AI & ML
Claude10%
Sign in to see how your skills match this stack
Sign In
Full uniQure tech stack
22 technologies · by team · pay by technology · changes · similar stacks
Salary insights
Compensation ranges based on this company's open jobs
Median
$265k
Typical range
$113k – $399k
Open positions
16
16
Jobs
Senior
25%
Architect
75%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Senior | 4 | $174k | $113k – $332k |
| Architect | 12 | $265k | $222k – $399k |
Highest paying role
Vice President, Regulatory Strategy
$399k
Normalized to USD per year
All salaries at uniQure
By role, level and city, against the market · 16 jobs with pay
Growth
Hiring Momentum
32/100
Slowing
Open positions
21
2 opened / 0 closed in 30 days
ATS activity
Every ~3 hours
Today
Hiring Dynamics
0%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Finance
14% ▲
Legal
14% ▲
Analytics
10% ▲
Marketing
10% ▲
Operations
10% ▲
Public Policy
10% ▲
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
2
Busiest office
Lexington
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
Lexington
United States
Corporate office
US - Lexington
13 open roles 13 posted in 90 days 8% engineering 15% remote $269k Avg Salary
hires for Legal, Public Policy, Leadership
Amsterdam
Netherlands
Corporate office
NL - Amsterdam
5 open roles 5 posted in 90 days 20% engineering
hires for Finance, Data Science, Management
Jobs
$205k – $265k per year • In office • 10+ years exp • Bachelor's Degree • Lexington
Python
SQL
Snowflake
Microsoft Fabric
Cybersecurity
GDPR
Analytics
Power BI
Apply
$205k – $265k per year • In office • 10+ years exp • Master's Degree • Lexington
SAS
GDPR
Apply
$88k – $113k per year • In office • 8+ years exp • Lexington
Windows
Cybersecurity
GDPR
Microsoft Entra ID
Management
Microsoft Teams
OneDrive
SharePoint
ITIL
Apply
$275k – $332k per year • In office • 10+ years exp • Bachelor's Degree
Python
SQL
Snowflake
Microsoft Fabric
Cybersecurity
GDPR
Analytics
Power BI
Apply
≈ $86k – $205k per year (Estimated) • Hybrid • 5+ years exp • Amsterdam
Python
JavaScript
PHP
TypeScript
SQL
WordPress
Databases
Databricks
Microsoft Fabric
AI/ML
Copilot
Spark
Claude Code
DevOps
Azure DevOps
Azure
CI/CD
Cybersecurity
GDPR
OWASP
Analytics
Power BI
Apply